Search results for "ESTRÓGENOS"
showing 5 items of 5 documents
TFOS DEWS II Sex, Gender, and Hormones Report
2017
One of the most compelling features of dry eye disease (DED) is that it occurs more frequently in women than men. In fact, the female sex is a significant risk factor for the development of DED. This sex-related difference in DED prevalence is attributed in large part to the effects of sex steroids (e.g. androgens, estrogens), hypothalamic-pituitary hormones, glucocorticoids, insulin, insulin-like growth factor 1 and thyroid hormones, as well as to the sex chromosome complement, sex-specific autosomal factors and epigenetics (e.g. microRNAs). In addition to sex, gender also appears to be a risk factor for DED. âGenderâ and âsexâ are words that are often used interchangeably, but the…
Variants translating reduced expression of the beta estrogen receptor gene were associated with increased carotid intima media thickness : a cross-se…
2021
Abstract Background There is debate on the role of estrogens in modulating the risk for atherosclerosis in women. Our purpose was to investigate whether the size of the estrogenic impact was independently associated with variation of carotid intima-media thickness (IMT) in healthy late postmenopausal women. The levels of circulating estrogens have been used in previous studies but the influence of SNPs of the estrogen receptors (ER) α and β has not been investigated.Methods We performed a crossed-sectional study of 91 women in a university hospital. We used a double approach in which, in addition to the measurement of estradiol levels by ultrasensitive methods, genetic variants (SNPs) assoc…
Regulación por estradiol de la producción de Angiotensina 1-7 y papel del receptor Mas en la producción de óxido nítrico en células endoteliales huma…
2017
El sistema renina-angiotensina intracelular (SRA) está formado por un conjunto de enzimas y metabolitos que se han relacionado con la regulación de la función cardiovascular y con la fisiopatología de la hipertensión arterial. El SRA clásico o circulante interviene en la regulación vascular principalmente con los péptidos bioactivos angiotensina (Ang) I y Ang II. La enzima que regula el paso de Ang I a Ang II es la enzima de conversión de la angiotensina 1 (ECA-1, la primera que se describió). En el año 2000 se descubrió que la enzima de conversión de la angiotensina 2 (ECA-2) convertía la Ang II en Ang 1-7. La Ang 1-7 es una molécula del SRA que tiene efecto fundamentalmente vasodilatador.…
Interacción entre receptores de estrógenos, hipoxia, angiogénesis y metabolismo tumoral en cáncer de mama
2017
El cáncer de mama ocupa el primer lugar en incidencia y muerte por neoplasia maligna en mujeres en el mundo occidental. Sin embargo, la gran heterogeneidad de la enfermedad, hace que haya una necesidad creciente de biomarcadores no sólo para el diagnóstico preciso, sino también para el abordaje del paciente que permitan una medicina personalizada y de precisión. En términos generales existen tres factores que influyen notablemente en la agresividad de un tumor mamario. Por una parte, prevalece una fuerte correlación entre la proliferación y el receptor de estrógenos (ER). Por otra parte, la angiogénesis es necesaria para el aporte de nutrientes al tumor y juega así un papel fundamental en l…
A Pathology-Based Combined Model to Identify PAM50 Non-luminal Intrinsic Disease in Hormone Receptor-Positive HER2-Negative Breast Cancer
2019
No luminal; Subtipus intrínsec; Càncer de mama No luminal; Subtipo intrínseco; Cáncer de mama Non-luminal; Intrinsic subtype, Breast cancer Background: In hormone receptor-positive (HR+)/HER2-negative breast cancer, the HER2-enriched and Basal-like intrinsic subtypes are associated with poor outcome, low response to anti-estrogen therapy and high response to chemotherapy. To date, no validated biomarker exists to identify both molecular entities other than gene expression. Methods: PAM50 subtyping and immunohistochemical data were obtained from 8 independent studies of 1,416 HR+/HER2-negative early breast tumors. A non-luminal disease score (NOLUS) from 0 to 100, based on percentage of estr…